Trial Profile

Apixaban for the Secondary Prevention of Thromboembolism: A Prospective Randomized Outcome Pilot Study Among Patients With the AntiphosPholipid Syndrome

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Apixaban (Primary) ; Warfarin
Indications Thromboembolism
Focus Adverse reactions; Therapeutic Use
Acronyms ASTRO-APS

Most Recent Events

26 Sep 2023 Status changed from active, no longer recruiting to completed.
24 Aug 2021 Planned End Date changed from 1 Jul 2021 to 1 Oct 2021.
13 Jun 2019 Planned End Date changed from 1 Dec 2019 to 1 Jul 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com